Olafson Carly, William Nishaka, Howell Anita, Beaudin Lynnette, Gill Balkar, Clarke Gwen, Stephens Stephanie, Lopes-Carvalho Dora, Lane Debra, Schubert Peter, McTaggart Ken, Acker Jason P
Innovation and Portfolio Management, Canadian Blood Services, Edmonton, Alberta, Canada.
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
Transfusion. 2022 Aug;62(8):1506-1510. doi: 10.1111/trf.17027. Epub 2022 Jul 23.
Preparing small-dose red cell concentrates (RCCs) is a common practice for pediatric and neonatal transfusions. However, there is a lack of quality monitoring data to indicate that both the preparation and storage of small-dose RCCs does not alter in vitro red cell quality. The present study seeks to provide data to support this practice.
To evaluate quality of stored small aliquots, six ABO/Rh matched leukoreduced citrate phosphate-dextrose/saline-adenine-glucose-mannitol (LR CPD/SAGM) RCCs were pooled and split into 30 ml aliquots, 80 ml aliquots, and a standard 290 ml unit, with testing performed for up to 43 days post-collection. To evaluate the impact of irradiation on small-dose RCC preparation, a total of 48 independent LR CPD/SAGM RCCs were used (non-irradiated: n = 24; irradiated: n = 24). Aliquoting with/without irradiation was performed within 7 days of collection and baseline testing was performed within 24 h of aliquot production.
Limited variability in hemolysis, mean cell volume, and extracellular potassium concentrations were seen between the different aliquot sizes throughout the 43-day storage period. Aliquot production did not accentuate damage based on any of these tested parameters in both the non-irradiated and irradiated subsets. A significant increase was seen in the potassium concentrations in the irradiated parent and aliquot samples relative to their non-irradiated counterparts.
Non-irradiated small-aliquot dose RCCs meet in vitro quality criteria required for safe transfusion throughout the 42-day storage period. The same can be said for aliquots derived from irradiated units and tested within 24 h of aliquot production.
制备小剂量红细胞浓缩液(RCCs)是儿科和新生儿输血的常见做法。然而,缺乏质量监测数据表明小剂量RCCs的制备和储存不会改变体外红细胞质量。本研究旨在提供数据支持这一做法。
为评估储存的小份样本的质量,将6份ABO/Rh血型匹配的白细胞滤除的枸橼酸盐磷酸盐-葡萄糖/生理盐水-腺嘌呤-葡萄糖-甘露醇(LR CPD/SAGM)RCCs合并,分成30ml小份、80ml小份和标准的290ml单位,在采集后长达43天进行检测。为评估辐照对小剂量RCCs制备的影响,共使用48份独立的LR CPD/SAGM RCCs(未辐照:n = 24;辐照:n = 24)。在采集后7天内进行有/无辐照的分装,并在分装后24小时内进行基线检测。
在43天的储存期内,不同分装体积之间的溶血、平均细胞体积和细胞外钾浓度变化有限。在未辐照和辐照亚组中,基于任何这些测试参数,分装过程均未加剧损伤。与未辐照的对应样本相比,辐照的母样本和分装样本中的钾浓度显著增加。
未辐照的小剂量分装RCCs在42天储存期内符合安全输血所需的体外质量标准。对于源自辐照单位并在分装后24小时内进行检测的分装样本,情况也是如此。